165 related articles for article (PubMed ID: 34060984)
1. A novel delivery of curcumin by the efficient nanoliposomal approach against
Fattahi Bafghi A; Haghirosadat BF; Yazdian F; Mirzaei F; Pourmadadi M; Pournasir F; Hemati M; Pournasir S
Prep Biochem Biotechnol; 2021; 51(10):990-997. PubMed ID: 34060984
[TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of nanoliposomes berberine chloride against Leishmania major promastigotes.
Bafghi AF; Mirzaei F; Norouzi R; Haghirosadat F; Pournasir S; Pournasir F; Siyadatpanah A
Ann Parasitol; 2021; 67(4):637-646. PubMed ID: 35247304
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of artemether-loaded niosomes in Leishmania major-induced cutaneous leishmaniasis.
Niroumand U; Motazedian MH; Ahmadi F; Asgari Q; Bahreini MS; Ghasemiyeh P; Mohammadi-Samani S
Sci Rep; 2024 May; 14(1):10073. PubMed ID: 38698123
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo anti-parasitic activity of curcumin nanoemulsion on Leishmania major (MRHO/IR/75/ER).
Sahebi K; Shahsavani F; Mehravar F; Hatam G; Alimi R; Radfar A; Bahreini MS; Pouryousef A; Teimouri A
BMC Complement Med Ther; 2024 Jun; 24(1):238. PubMed ID: 38890586
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo anti-parasitic activity of biogenic antimony sulfide nanoparticles on Leishmania major (MRHO/IR/75/ER).
Mohtasebi S; Mohebali M; Elikaee S; Akhoundi B; Foroushani AR; Teimouri A; Yarizadeh H
Parasitol Res; 2019 Sep; 118(9):2669-2678. PubMed ID: 31278518
[TBL] [Abstract][Full Text] [Related]
6. The activity of encapsulated meglumine antimoniate in stearylamine-bearing liposomes against cutaneous leishmaniasis in BALB/c mice.
Moosavian SA; Fallah M; Jaafari MR
Exp Parasitol; 2019 May; 200():30-35. PubMed ID: 30898544
[TBL] [Abstract][Full Text] [Related]
7. Investigation of anti-leishmanial efficacy of miltefosine and ketoconazole loaded on nanoniosomes.
Nazari-Vanani R; Vais RD; Sharifi F; Sattarahmady N; Karimian K; Motazedian MH; Heli H
Acta Trop; 2018 Sep; 185():69-76. PubMed ID: 29733808
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of curcumin and CM11 peptide alone and in combination against amastigote form of Iranian strain of L. major (MRHO/IR75/ER) in vitro.
Aqeele G; Shayan P; Ebrahimzade Abkooh E; Mohebali M
Exp Parasitol; 2021 Oct; 229():108151. PubMed ID: 34419412
[TBL] [Abstract][Full Text] [Related]
9. Formulation and Characterization of a Self-Emulsifying Drug Delivery System (SEDDS) of Curcumin for the Topical Application in Cutaneous and Mucocutaneous Leishmaniasis.
Khan M; Nadhman A; Sehgal SA; Siraj S; Yasinzai MM
Curr Top Med Chem; 2018; 18(18):1603-1609. PubMed ID: 30360717
[TBL] [Abstract][Full Text] [Related]
10. Fe3O4
Albalawi AE; Khalaf AK; Alyousif MS; Alanazi AD; Baharvand P; Shakibaie M; Mahmoudvand H
Biomed Pharmacother; 2021 Jul; 139():111566. PubMed ID: 33839494
[TBL] [Abstract][Full Text] [Related]
11. Anti-proliferative and apoptosis induction activities of curcumin on Leishmania major.
Elamin M; Al-Olayan E; Abdel-Gaber R; Yehia RS
Rev Argent Microbiol; 2021; 53(3):240-247. PubMed ID: 33531168
[TBL] [Abstract][Full Text] [Related]
12. Amphotericin B-loaded nanoparticles for local treatment of cutaneous leishmaniasis.
Abu Ammar A; Nasereddin A; Ereqat S; Dan-Goor M; Jaffe CL; Zussman E; Abdeen Z
Drug Deliv Transl Res; 2019 Feb; 9(1):76-84. PubMed ID: 30484256
[TBL] [Abstract][Full Text] [Related]
13. A Systematic Review of Curcumin and its Derivatives as Valuable Sources of Antileishmanial Agents.
Albalawi AE; Alanazi AD; Sharifi I; Ezzatkhah F
Acta Parasitol; 2021 Sep; 66(3):797-811. PubMed ID: 33770343
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the Effect of Cinnarizine on Promastigotes and Amastigotes forms of Leishmania major.
Sarouey LA; Rahimi-Moghaddam P; Tabatabaie F; Khanaliha K
Infect Disord Drug Targets; 2020; 20(4):550-555. PubMed ID: 30421686
[TBL] [Abstract][Full Text] [Related]
15. Development of liposomes loaded with anti-leishmanial drugs for the treatment of cutaneous leishmaniasis.
Momeni A; Rasoolian M; Momeni A; Navaei A; Emami S; Shaker Z; Mohebali M; Khoshdel A
J Liposome Res; 2013 Jun; 23(2):134-44. PubMed ID: 23350940
[TBL] [Abstract][Full Text] [Related]
16. Determination of the Effective Dose of Curcumin alone and in Combination with Antimicrobial Peptide CM11 on Promastigote Forms of Iranian Strain of L. major (MRHO / IR / 75 / ER).
Aqeele G; Shayan P; Ebrahimzadeh E; Mohebali M; Khalili S
Arch Razi Inst; 2019 Dec; 74(4):413-422. PubMed ID: 31939258
[TBL] [Abstract][Full Text] [Related]
17. Anti-leishmanial effects of resveratrol and resveratrol nanoemulsion on Leishmania major.
Mousavi P; Rahimi Esboei B; Pourhajibagher M; Fakhar M; Shahmoradi Z; Hejazi SH; Hassannia H; Nasrollahi Omran A; Hasanpour H
BMC Microbiol; 2022 Feb; 22(1):56. PubMed ID: 35168553
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of manganese oxide (Mn
Tavakoli P; Ghaffarifar F; Delavari H; Shahpari N
J Trace Elem Med Biol; 2019 Dec; 56():162-168. PubMed ID: 31473559
[TBL] [Abstract][Full Text] [Related]
19. Nanoliposomal artemisinin for the treatment of murine visceral leishmaniasis.
Want MY; Islammudin M; Chouhan G; Ozbak HA; Hemeg HA; Chattopadhyay AP; Afrin F
Int J Nanomedicine; 2017; 12():2189-2204. PubMed ID: 28356736
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen Induces Apoptosis of Leishmania major Promastigotes in Vitro.
Doroodgar M; Delavari M; Doroodgar M; Abbasi A; Taherian AA; Doroodgar A
Korean J Parasitol; 2016 Feb; 54(1):9-14. PubMed ID: 26951973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
